Back to Journals » Neuropsychiatric Disease and Treatment » Volume 15

Neuropsychiatric Disease and Treatment


Archive: Volume 15, 2019

Cytokines and chemokines expression in serum of patients with neuromyelitis optica

Ai NP, Liu HJ, Zhou HF, Lin DH, Wang JQ, Yang M, Song HG, Sun MM, Xu QG, Wei SH

Neuropsychiatric Disease and Treatment 2019, 15:303-310

Published Date: 21 January 2019

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia

Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T

Neuropsychiatric Disease and Treatment 2019, 15:293-301

Published Date: 21 January 2019

Altered intrinsic brain activity in patients with toothaches using the amplitude of low-frequency fluctuations: a resting-state fMRI study

Yang J, Li B, Yu QY, Ye L, Zhu PW, Shi WQ, Yuan Q, Min YL, He YL, Shao Y

Neuropsychiatric Disease and Treatment 2019, 15:283-291

Published Date: 18 January 2019

Frequency-dependent neural activity in primary angle-closure glaucoma

Jiang F, Yu C, Zuo MJ, Zhang C, Wang Y, Zhou FQ, Zeng XJ

Neuropsychiatric Disease and Treatment 2019, 15:271-282

Published Date: 18 January 2019

Association between anxious distress in a major depressive episode and bipolarity

Sugawara H, Tsutsumi T, Inada K, Ishigooka J, Hashimoto M, Takebayashi M, Nishimura K

Neuropsychiatric Disease and Treatment 2019, 15:267-270

Published Date: 15 January 2019

Serum BICC1 levels are significantly different in various mood disorders

Chen S, Jiang H, Xu Z, Zhao J, Wang M, Lu Y, Li J, Sun F, Yuan Y

Neuropsychiatric Disease and Treatment 2019, 15:259-265

Published Date: 15 January 2019

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder

Zvěřová M, Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, Lambertová A, Raboch J

Neuropsychiatric Disease and Treatment 2019, 15:233-240

Published Date: 14 January 2019

Lower vitamin D levels are associated with depression in patients with gout

Zhou Q, Shao Y, Gan Z, Fang L

Neuropsychiatric Disease and Treatment 2019, 15:227-231

Published Date: 14 January 2019

Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1

Endo M, Odaira K, Ono R, Kurauchi G, Koseki A, Goto M, Sato Y, Kon S, Watanabe N, Sugawara N, Takada H, Kimura E

Neuropsychiatric Disease and Treatment 2019, 15:219-226

Published Date: 14 January 2019

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele

Yin J, Feng W, Yuan H, Yuan J, Wu Y, Liu X, Jin C, Cheng Z

Neuropsychiatric Disease and Treatment 2019, 15:213-218

Published Date: 11 January 2019

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:205-211

Published Date: 9 January 2019

Prevalence and associated factors of comorbid anxiety disorders in late-life depression: findings from geriatric tertiary outpatient settings

Suradom C, Wongpakaran N, Wongpakaran T, Lerttrakarnnon P, Jiraniramai S, Taemeeyapradit U, Lertkachatarn S, Arunpongpaisal S

Neuropsychiatric Disease and Treatment 2019, 15:199-204

Published Date: 7 January 2019

The impact of short and long sleep duration on instrumental activities of daily living among stroke survivors

Seixas AA, Chung DP, Richards SL, Madhavaram S, Raghavan P, Gago J, Casimir G, Jean-Louis G

Neuropsychiatric Disease and Treatment 2019, 15:177-182

Published Date: 4 January 2019

Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment

Albai O, Frandes M, Timar R, Roman D, Timar B

Neuropsychiatric Disease and Treatment 2019, 15:167-175

Published Date: 3 January 2019

Risk factors for the difficulties in general activities across the day in Chinese children and adolescents with attention-deficit/hyperactivity disorder

Ke X, Du Y, Zheng Y, Su L, Chen Y, Zhang YL, Chen K, Cheng Y, Chen W

Neuropsychiatric Disease and Treatment 2019, 15:157-166

Published Date: 31 December 2018

Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis

Xu F, Wang B, Yao J

Neuropsychiatric Disease and Treatment 2019, 15:143-155

Published Date: 28 December 2018

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff

Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:137-142

Published Date: 27 December 2018

Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis

Ghaffarpasand F, Torabi S, Rasti A, Niakan MH, Aghabaklou S, Pakzad F, Beheshtian MS, Tabrizi R

Neuropsychiatric Disease and Treatment 2019, 15:127-135

Published Date: 27 December 2018

Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning

Carmassi C, Dell’Oste V, Ceresoli D, Moscardini S, Bianchi E, Landi R, Massimetti G, Nisita C, Dell’Osso L

Neuropsychiatric Disease and Treatment 2019, 15:115-125

Published Date: 24 December 2018

Poststroke epilepsy: current perspectives on diagnosis and treatment

Sarecka-Hujar B, Kopyta I

Neuropsychiatric Disease and Treatment 2019, 15:95-103

Published Date: 24 December 2018

Associations of BRAP polymorphisms with the risk of alcohol dependence and scores on the Alcohol Use Disorders Identification Test

Kim JW, Choe YM, Shin JG, Park BL, Shin HD, Choi IG, Lee BC

Neuropsychiatric Disease and Treatment 2019, 15:83-94

Published Date: 24 December 2018

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder

Brown EC, Clark DL, Hassel S, MacQueen G, Ramasubbu R

Neuropsychiatric Disease and Treatment 2019, 15:75-82

Published Date: 21 December 2018

The factor structure, reliability and validity of the Chinese version of the Van Dream Anxiety Scale

Wang X, Dai L, Yin M, Deng YL

Neuropsychiatric Disease and Treatment 2019, 15:57-67

Published Date: 21 December 2018

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm

Dong H, Fan S, Luo Y, Peng B

Neuropsychiatric Disease and Treatment 2019, 15:33-36

Published Date: 19 December 2018

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

Yi ZM, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD

Neuropsychiatric Disease and Treatment 2019, 15:1-19

Published Date: 17 December 2018